Why it matters
People who use the affected medication may need information about whether their product is included. The article does not identify lot numbers or describe the potential health effects.
This brief summarizes public reporting and official announcements. Research findings may be preliminary. Talk to a qualified clinician before making health decisions.
This event has left the current brief. The summary below describes the stored record; open the original sources for current conditions.
Vitaris is recalling nearly 22,000 bottles of generic telmisartan and amlodipine tablets in 40-milligram and 5-milligram doses, according to The Epoch Times. The article describes the issue as “superpotency” but provides no further recall details.
HOW THIS BRIEF WAS MADE 1 outlet: 1 national. Automated sourcing and summaries by the BLUF engine. Corrections
People who use the affected medication may need information about whether their product is included. The article does not identify lot numbers or describe the potential health effects.